undamentalytics Newsletter

Geron Corp insider trading

Every open-market purchase and sale by Geron Corp's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.

No insider has bought shares on the open market in five years.

Insider purchase Insider sale Marker size reflects trade value. Weekly closes adjusted for splits; may be delayed.
Geron Corp insider open-market trades
DateInsiderTrade SharesPriceValue 1M after 3M after 6M after

From insiders' Form 4 filings with the SEC: open-market purchases and sales only (awards, option exercises and shares withheld for tax are excluded), combined to one line per insider per day. "Plan" marks trades the filing says were made under a pre-set Rule 10b5-1 trading plan, which are scheduled in advance. Price changes run from the close on the trade date; hover a figure for the change relative to the S&P 500. Past moves don't predict future ones.

Does following Geron Corp’s insiders pay?

From April 30, 2010 to February 19, 2026, 20 insiders reported 10 open-market purchases and 37 sales not made under a pre-set plan in Geron Corp. After sales, the shares moved −43.5% against the index over 12 months (a negative figure means selling was the right call).

Geron Corp: each insider's record
InsiderRolePurchases12 months after their purchasesBeat the S&P 500Sales12 months after their salesLatest report
Behrs Melissa Kelly EVP Portfolio & Alliance Mgmt 0 — — 8 −44.7% (1) May 30, 2014
Earp David SVP, Corp Transactions 0 — — 5 −44.7% (1) June 1, 2012
Greenwood David President, Interim CEO, CFO 0 — — 4 −44.7% (1) June 16, 2011
Kelsey Stephen Michael EVP, R&D Head, CMO 0 — — 4 −36.6% (1) June 1, 2012
Lebkowski Jane SVP, Chief Scientific Officer 0 — — 4 −44.7% (1) June 16, 2011
Bloom Olivia Kyusuk EVP, Chief Financial Officer 0 — — 3 — April 2, 2014
Kiley Thomas Director 2 — — 0 — November 23, 2011
O'farrell Elizabeth G. Director 2 — — 0 — August 24, 2023
Okarma Thomas President and CEO 0 — — 2 −44.7% (1) June 3, 2010
Scarlett John A Chairman, President and CEO 2 — — 0 — March 3, 2025
Spink Katharine E. SVP Alliance Mgmt & Operations 0 — — 2 −44.7% (1) June 16, 2011
Bradbury Daniel Director 1 — — 0 — May 12, 2014
Feller Faye EVP, Chief Medical Officer 0 — — 1 — June 12, 2024
Grethlein Andrew J EVP, Chief Operating Officer 0 — — 1 — July 10, 2024
Hofstaetter Thomas Director 0 — — 1 — March 19, 2015
Kapur Anil EVP, Corp Strategy & CCO 0 — — 1 — June 12, 2024
Lawlis V Bryan Director 1 — — 0 — May 13, 2025
Robertson Michelle EVP, CHIEF FINANCIAL OFFICER 0 — — 1 — February 19, 2026
Samuels Scott Alan EVP, Chief Legal Officer 1 — — 0 — March 3, 2025
Ziegler James EVP, Chief Commercial Officer 1 — — 0 — March 3, 2025

Moves are the shares’ return including dividends minus the S&P 500’s, from the close on the first trading day after each report; the number of trades with a finished 12-month window is in brackets. Green means the trade went the insider’s way (a purchase ahead of the index, a sale followed by the shares trailing it). A trade reported both by a director or officer and by a fund or company they are linked to counts once here, under the person. Purchases count only where the share price actually traded was at least $5. These figures describe what the shares did, not why anyone traded. Insiders across all companies.

When several insiders traded Geron Corp

Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Geron Corp in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After 1 selling crowd, −2.1%. One company's history is too short to judge by; the test across every company is the better guide.

MonthCrowd3 months on, vs S&P 5006 months12 months
May 28, 20106 selling−5.4%−2.1%−40.2%

Colours show whether the crowd was right: green when buyers were followed by a rise above the index, or sellers by a fall below it. Total returns from the month end; past patterns are not a forecast.

← Back to Geron Corp · Funds · Politicians